2518 Participants Needed

Co-Scheduled Newborn and Contraception Care for Postpartum Women

(LINCC Trial)

Recruiting at 4 trial locations
IA
EO
Overseen ByEmily Ott, MS
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: Rush University Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Pregnancies conceived within 18 months of a prior delivery (termed short inter-pregnancy interval \[IPI\]) place mothers and infants at high risk for poor health outcomes and affect nearly one third of women in the U.S. Rates of postpartum (PP) contraception use remain low, particularly among low-income minority women, leading to high rates of short IPI pregnancies. This proposed study aims to address the gap in the current model of PP contraception care, by developing and implementing a novel approach to link (co-schedule) PP contraception care with newborn well-baby care with the goal of improving access to timely PP contraception.

Who Is on the Research Team?

SH

Sadia Haider, MD

Principal Investigator

Rush University Medical Center

RC

Rachel Caskey, MD

Principal Investigator

University of Illinois at Chicago

Are You a Good Fit for This Trial?

This trial is for women who have recently given birth and are visiting one of the selected 7 CHC sites with their infants for the first well-baby visit, typically 3-5 days post-delivery. It's not open to men, or women who had tubal ligation or planned long-term birth control right after delivery, nor those who needed an emergency hysterectomy.

Inclusion Criteria

Eligible participants include women presenting with their infants at one of the 7 chosen CHC sites for their first WBV (typically 3-5 days after delivery).

Exclusion Criteria

I have not had an emergency hysterectomy due to bleeding during delivery.
I am not eligible for the study as it is only for female patients.
I have not had a tubal ligation or plan to use long-term birth control right after giving birth.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive co-scheduled postpartum contraception and newborn care visits

6 months
Visits co-scheduled with well-baby visits

Follow-up

Participants are monitored for receipt of contraception and short inter-pregnancy interval pregnancies

24 months

What Are the Treatments Tested in This Trial?

Interventions

  • LINCC intervention - enable co-schedule feature
Trial Overview The study is testing a new approach called LINCC intervention that links postpartum contraception care with newborn baby care by scheduling them together. The goal is to improve access to timely postpartum contraception and reduce health risks associated with pregnancies occurring close together.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention - Aim 2Experimental Treatment1 Intervention
Group II: Control - Aim 2Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rush University Medical Center

Lead Sponsor

Trials
448
Recruited
247,000+

AllianceChicago

Collaborator

Trials
8
Recruited
18,700+

University of Illinois at Chicago

Collaborator

Trials
653
Recruited
1,574,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security